Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial

BACKGROUND: We previously reported the efficacy of the adjuvanted-protein COVID-19 vaccine candidate S-Trimer (SCB-2019) in adults who showed no evidence of previous exposure to SARS-CoV-2. In this study, we aimed to investigate the extent of protection afforded by previous exposure to SARS-CoV-2 on...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolenov, Igor, Han, Htay Htay, Li, Ping, Baccarini, Carmen, Verhoeven, Carole, Rockhold, Frank, Clemens, Sue Ann Costa, Ambrosino, Donna, Richmond, Peter, Siber, George, Liang, Joshua, Clemens, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015644/
https://www.ncbi.nlm.nih.gov/pubmed/35447085
http://dx.doi.org/10.1016/S1473-3099(22)00144-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015644/
https://www.ncbi.nlm.nih.gov/pubmed/35447085
http://dx.doi.org/10.1016/S1473-3099(22)00144-X

Ejemplares similares